Investing

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

by admin
RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

Related Posts

Crypto Market Recap: Bitcoin Price Hits New All-time...

May 22, 2025

Operational Update

June 4, 2025

A$3.5M Institutional Placement and New Chairman Appointed

May 26, 2025

Multiple Uranium Anomalies Identified at Key NT Projects

May 15, 2025

CHARBONE Hydrogen Announces Insiders Investment and Other Corporate...

May 14, 2025

What is the VIX Index?

April 29, 2025

Precious Metals & Critical Minerals Hybrid Investor Conference...

May 17, 2025

Crypto Market Recap: $TRUMP Token Soars as President...

April 28, 2025

Silver Stocks and the Land Grab for Silver...

May 29, 2025

Wildfires Slash Canadian Oil Output by 7 Percent

June 5, 2025